Results 1 to 10 of about 74,737 (254)

International Guillain-Barré Syndrome Outcome Study (IGOS): protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome [PDF]

open access: yes, 2017
Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy with a highly variable clinical presentation, course, and outcome. The factors that determine the clinical variation of GBS are poorly understood which complicates the care and treatment of
Bateman, K.   +49 more
core   +39 more sources

A rare case of paraneoplastic Guillain-Barré syndrome in a patient with endometrial cancer

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2023
Introduction: Guillain-Barré syndrome is an acute, inflammatory polyradiculoneuropathy of autoimmune aetiology. It is a rare disease seen in 1 in 100,000 person-years.
Asif Mohamed Farook   +3 more
doaj   +1 more source

Acute onset of Guillain-Barré syndrome after multiple spine surgeries: A rare case report

open access: yesAdvanced Biomedical Research, 2022
Guillain-Barré syndrome is an autoimmune disorder presented by ascending paralysis and areflexia. The condition has been reported after many infections, but Guillain-Barré syndrome after spine surgery is rare. We, herein, present a case of Guillain-Barré
Khalil Komlakh   +5 more
doaj   +1 more source

European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome

open access: yesEuropean Journal of Neurology, 2023
Guillain–Barré syndrome (GBS) is an acute polyradiculoneuropathy. Symptoms may vary greatly in presentation and severity. Besides weakness and sensory disturbances, patients may have cranial nerve involvement, respiratory insufficiency, autonomic ...
Pieter A. Doorn   +20 more
semanticscholar   +1 more source

Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine

open access: yesCureus, 2021
Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications.
S. Waheed   +4 more
semanticscholar   +1 more source

Prevalence, clinical characteristics and outcomes of Guillain−Barré syndrome spectrum associated with COVID‐19: A systematic review and meta‐analysis

open access: yesEuropean Journal of Neurology, 2021
Mounting evidence supports an association between Guillain−Barré syndrome spectrum (GBSs) and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection.
L. Palaiodimou   +13 more
semanticscholar   +1 more source

Guillain–Barré Syndrome Associated with SARS-CoV-2

open access: yesNew England Journal of Medicine, 2020
Guillain–Barre Syndrome with Covid-19 Five patients who had Guillain–Barre syndrome 5 to 10 days after the onset of Covid-19 are described.
G. Toscano   +11 more
semanticscholar   +1 more source

Guillain Barre syndrome associated with COVID-19 infection: A case report

open access: yesJournal of clinical neuroscience, 2020
Novel outbreak with coronavirus 2019 began since 31 December 2019. Coronaviruses can cause multiple systemic infections that respiratory complications are the most obvious symptoms. In this report, we describe the symptoms of Guillain Barre syndrome (GBS)
Z. Sedaghat, N. Karimi
semanticscholar   +1 more source

Guillain–Barré Syndrome Variant Occurring after SARS‐CoV‐2 Vaccination

open access: yesAnnals of Neurology, 2021
Although SARS‐CoV‐2 vaccines are very safe, we report 4 cases of the bifacial weakness with paresthesias variant of Guillain–Barré syndrome (GBS) occurring within 3 weeks of vaccination with the Oxford–AstraZeneca SARS‐CoV‐2 vaccine.
C. Allen   +6 more
semanticscholar   +1 more source

Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases

open access: yesJournal of Neurology, 2020
Since coronavirus disease-2019 (COVID-19) outbreak in January 2020, several pieces of evidence suggested an association between the spectrum of Guillain–Barré syndrome (GBS) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Samir Abu-Rumeileh   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy